002793 罗欣药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.618-50.127-23.425-32.4089.637
总资产报酬率 ROA (%)0.551-20.426-9.990-13.9074.716
投入资产回报率 ROIC (%)0.690-25.427-11.791-16.8026.042

边际利润分析
销售毛利率 (%)51.76642.14446.27826.74150.190
营业利润率 (%)3.253-36.206-24.810-40.6677.360
息税前利润/营业总收入 (%)5.700-33.828-22.876-37.4638.967
净利润/营业总收入 (%)1.947-39.747-32.528-35.0466.509

收益指标分析
经营活动净收益/利润总额(%)-24.59649.07672.963111.686108.534
价值变动净收益/利润总额(%)-8.56322.730-1.902-11.182-0.671
营业外收支净额/利润总额(%)-9.259-0.5922.9190.2741.740

偿债能力分析
流动比率 (X)0.8140.7031.0781.0791.589
速动比率 (X)0.6370.5220.8410.9231.412
资产负债率 (%)61.65366.34249.73259.26550.133
带息债务/全部投入资本 (%)50.25653.47736.20051.35639.439
股东权益/带息债务 (%)89.27775.750163.14987.912147.289
股东权益/负债合计 (%)59.04348.05397.04965.98392.093
利息保障倍数 (X)2.094-15.628-8.536-11.2996.070

营运能力分析
应收账款周转天数 (天)83.28373.000104.563200.819157.074
存货周转天数 (天)134.374107.551161.67095.47675.613